• Je něco špatně v tomto záznamu ?

KDIGO Controversies Conference on onco-nephrology: understanding kidney impairment and solid-organ malignancies, and managing kidney cancer

C. Porta, A. Bamias, FR. Danesh, A. Dębska-Ślizień, M. Gallieni, MA. Gertz, JT. Kielstein, P. Tesarova, G. Wong, M. Cheung, DC. Wheeler, WC. Winkelmayer, J. Małyszko, Conference Participants

. 2020 ; 98 (5) : 1108-1119. [pub] -

Jazyk angličtina Země Spojené státy americké

Typ dokumentu směrnice pro lékařskou praxi, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc21019918

The association between kidney disease and cancer is multifaceted and complex. Persons with chronic kidney disease (CKD) have an increased incidence of cancer, and both cancer and cancer treatments can cause impaired kidney function. Renal issues in the setting of malignancy can worsen patient outcomes and diminish the adequacy of anticancer treatments. In addition, the oncology treatment landscape is changing rapidly, and data on tolerability of novel therapies in patients with CKD are often lacking. Caring for oncology patients has become more specialized and interdisciplinary, currently requiring collaboration among specialists in nephrology, medical oncology, critical care, clinical pharmacology/pharmacy, and palliative care, in addition to surgeons and urologists. To identify key management issues in nephrology relevant to patients with malignancy, KDIGO (Kidney Disease: Improving Global Outcomes) assembled a global panel of multidisciplinary clinical and scientific expertise for a controversies conference on onco-nephrology in December 2018. This report covers issues related to kidney impairment and solid organ malignancies as well as management and treatment of kidney cancer. Knowledge gaps, areas of controversy, and research priorities are described.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21019918
003      
CZ-PrNML
005      
20210830101529.0
007      
ta
008      
210728s2020 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.kint.2020.06.046 $2 doi
035    __
$a (PubMed)33126977
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Porta, Camillo $u Department of Internal Medicine and Therapeutics, University of Pavia and Division of Translational Oncology, IRCCS Istituti Clinici Scientifici Maugeri, Pavia, Italy. Electronic address: camillo.porta@gmail.com
245    10
$a KDIGO Controversies Conference on onco-nephrology: understanding kidney impairment and solid-organ malignancies, and managing kidney cancer / $c C. Porta, A. Bamias, FR. Danesh, A. Dębska-Ślizień, M. Gallieni, MA. Gertz, JT. Kielstein, P. Tesarova, G. Wong, M. Cheung, DC. Wheeler, WC. Winkelmayer, J. Małyszko, Conference Participants
520    9_
$a The association between kidney disease and cancer is multifaceted and complex. Persons with chronic kidney disease (CKD) have an increased incidence of cancer, and both cancer and cancer treatments can cause impaired kidney function. Renal issues in the setting of malignancy can worsen patient outcomes and diminish the adequacy of anticancer treatments. In addition, the oncology treatment landscape is changing rapidly, and data on tolerability of novel therapies in patients with CKD are often lacking. Caring for oncology patients has become more specialized and interdisciplinary, currently requiring collaboration among specialists in nephrology, medical oncology, critical care, clinical pharmacology/pharmacy, and palliative care, in addition to surgeons and urologists. To identify key management issues in nephrology relevant to patients with malignancy, KDIGO (Kidney Disease: Improving Global Outcomes) assembled a global panel of multidisciplinary clinical and scientific expertise for a controversies conference on onco-nephrology in December 2018. This report covers issues related to kidney impairment and solid organ malignancies as well as management and treatment of kidney cancer. Knowledge gaps, areas of controversy, and research priorities are described.
650    _2
$a lidé $7 D006801
650    _2
$a ledviny $7 D007668
650    12
$a nádory ledvin $x epidemiologie $x terapie $7 D007680
650    _2
$a lékařská onkologie $7 D008495
650    12
$a nefrologie $7 D009398
650    12
$a chronická renální insuficience $x komplikace $x diagnóza $x epidemiologie $7 D051436
655    _2
$a směrnice pro lékařskou praxi $7 D017065
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Bamias, Aristotelis $u Second Propaedeutic Department of Internal Medicine, National and Kapodistrian University of Athens, Greece
700    1_
$a Danesh, Farhad R $u Section of Nephrology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
700    1_
$a Dębska-Ślizień, Alicja $u Clinical Department of Nephrology, Transplantology and Internal Medicine, Medical University of Gdańsk, Gdańsk, Poland
700    1_
$a Gallieni, Maurizio $u Nephrology and Dialysis Unit, Luigi Sacco Department of Biomedical and Clinical Sciences, Università di Milano, Milan, Italy
700    1_
$a Gertz, Morie A $u Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA
700    1_
$a Kielstein, Jan T $u Medical Clinic V, Nephrology, Rheumatology, Blood Purification, Academic Teaching Hospital Braunschweig, Braunschweig, Germany
700    1_
$a Tesarova, Petra $u Department of Oncology, 1st Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic
700    1_
$a Wong, Germaine $u Centre for Kidney Research, The Children's Hospital at Westmead, Westmead, New South Wales, Australia; Sydney School of Public Health, University of Sydney, New South Wales, Australia
700    1_
$a Cheung, Michael $u KDIGO, Brussels, Belgium
700    1_
$a Wheeler, David C $u Department of Renal Medicine, University College London, London, UK; George Institute for Global Health, Sydney, Australia
700    1_
$a Winkelmayer, Wolfgang C $u Selzman Institute for Kidney Health, Section of Nephrology, Department of Medicine, Baylor College of Medicine, Houston, Texas, USA
700    1_
$a Małyszko, Jolanta $u Department of Nephrology, Dialysis, and Internal Medicine, Medical University of Warsaw, Poland. Electronic address: jolmal@poczta.onet.pl
710    2_
$a Conference Participants
773    0_
$w MED00010141 $t Kidney international $x 1523-1755 $g Roč. 98, č. 5 (2020), s. 1108-1119
856    41
$u https://pubmed.ncbi.nlm.nih.gov/33126977 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20210728 $b ABA008
991    __
$a 20210830101529 $b ABA008
999    __
$a ok $b bmc $g 1690676 $s 1140364
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 98 $c 5 $d 1108-1119 $e - $i 1523-1755 $m Kidney international $n Kidney Int $x MED00010141
LZP    __
$a Pubmed-20210728

Najít záznam

Citační ukazatele

Možnosti archivace